UCL  IRIS
Institutional Research Information Service
UCL Logo
Please report any queries concerning the funding data grouped in the sections named "Externally Awarded" or "Internally Disbursed" (shown on the profile page) to your Research Finance Administrator. Your can find your Research Finance Administrator at https://www.ucl.ac.uk/finance/research/rs-contacts.php by entering your department
Please report any queries concerning the student data shown on the profile page to:

Email: portico-services@ucl.ac.uk

Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
Publication Detail
A retrospective study of long-term outcomes in 152 patients with primary Sjogren's syndrome: 25-year experience.
  • Publication Type:
    Journal article
  • Publication Sub Type:
    Journal Article
  • Authors:
    Abrol E, González-Pulido C, Praena-Fernández JM, Isenberg DA
  • Publication date:
    04/2014
  • Pagination:
    157, 164
  • Journal:
    Clin Med (Lond)
  • Volume:
    14
  • Issue:
    2
  • Status:
    Published
  • Country:
    England
  • Print ISSN:
    1470-2118
  • PII:
    14/2/157
  • Language:
    eng
  • Keywords:
    Sjögren’s syndrome, autoimmune diseases, long-term follow-up, neoplasia, non-Hodgkin’s lymphoma, Adult, Aged, Autoimmune Diseases, Cohort Studies, Female, Follow-Up Studies, Humans, Lymphatic Diseases, Lymphoma, Non-Hodgkin, Male, Middle Aged, Neoplasms, Odds Ratio, Prognosis, Pulmonary Fibrosis, Retrospective Studies, Risk Factors, Sjogren's Syndrome, Thyroiditis, Autoimmune, Vasculitis
Abstract
The objective of this study was to evaluate the 25-year outcome of patients with primary Sjögren's syndrome (pSS). One hundred and fifty-two patients diagnosed with pSS (American-European classification criteria) were retrospectively and descriptively analysed (1986-2011). Of all 152 patients, 55.9% were alive, 18.4% had died and 25.7% discontinued follow-up (mostly due to old age). Malignancy affected 28.3% and non-Hodgkin's lymphoma (NHL) affected 10.5%. The adjusted risk for development of NHL was an odds ratio (OR) of 10.5 (95% confidence interval [CI]: 3.05-36.42) in patients with vasculitis (p<0.001), and OR 3.4 (95% CI 1.05-11.2) in the presence of glandular complications (parotid swelling, lymphadenopathy) (p < 0.041). Seventy-five patients (49.3%) developed other autoimmune diseases (autoimmune thyroid disease [15.8%], pulmonary fibrosis [7.2%] and vasculitis [10.5%]). Although the course of pSS is relatively benign, over 25 years patients experience more clinical complications than previously described. In addition, vasculitis and glandular manifestations were significant predictors for NHL.
Publication data is maintained in RPS. Visit https://rps.ucl.ac.uk
 More search options
UCL Researchers
University College London - Gower Street - London - WC1E 6BT Tel:+44 (0)20 7679 2000

© UCL 1999–2011

Search by